热门资讯> 正文
Annovis Bio GAAP EPS—6.23美元错过了3.15美元
2024-04-02 19:37
- Annovis Bio press release (NYSE:ANVS): FY GAAP EPS of -$6.23 misses by $3.15.
More on Annovis Bio
- Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects
- Annovis And Alzheimer's Disease: The Best-Laid Plans
- Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO
- Annovis to release efficacy data on Alzheimer's drug in April
- Annovis Bio falls after Brookline Capital downgrades on PD trial complications
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。